The oversubscribed round was led by Oyster Bay Venture Capital to advance research and development on plant-based materials.
"Once optimised and patented, we will raise our next round to co-locate this continuous process alongside a brewery, enabling immense production outputs. We initially applied our technology to beer breweries and whisky distilleries because of their robust supply chains. As part of this raise, we will also prioritise commercial partnerships to introduce products to the fashion and other industries, starting on a small scale."
The AI-native RegTech startup has secured pre-seed funding to accelerate product innovation, integrations, and team growth.
"While we’re not publicly disclosing specific figures, we’ve raised sufficient capital to execute the next phase of our growth. We’re investing in three core areas: product innovation (deepening our AI-native capabilities with richer regulatory intelligence and more automated workflows), ecosystem integrations (expanding our ability to connect seamlessly with existing financial systems and compliance tools), and team growth (hiring specialists in financial crime ops and AI to support our growing customer base and accelerate execution). Everything we do is focused on solving 95% of the problem that begins after an alert is triggered."
The financing was co-led by a16z speedrun and Concept Ventures to support product development and international growth.
"Dex’s mission is to empower individuals to do meaningful work byconnecting them with opportunities that align with their ambitions and values. Our aim is to redefine how talent and opportunity connect, globally. We’re working at the forefront of what is possible when it comes to conversational, generative AI and we’re thrilled to have some of the best AI investors in the world helping us to achieve that vision."
The property technology firm has opened its latest funding round to the public for the first time.
"The investment we’ve received so far reinforces the strength of our business model and has accelerated our progress. Opening our Series A investment round to the public for the first time goes one step further and represents a major milestone for us as a company."
EHE Ventures led the round with support from Deepbridge Capital and Lyva Labs to accelerate product development and regulatory approval.
"Spotlight Pathology represents exactly the type of highly innovative company that Deepbridge is privileged to invest in. We initially supported the team through our Seed Enterprise Investment Scheme (SEIS), and are now pleased to back them again through our EIS fund, alongside EHE and Lyva Labs. We look forward to supporting the team as they scale in the exciting field of digital pathology."
.png)